Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

Horvath, N; Spencer, A; Kenealy, M; Joshua, D; Campbell, P J; Lee, J J; Hou, J; Qiu, L; Kalff, A; Khong, T; Londhe, A; Siggins, S; van Kooten Losio, M; Eisbacher, M; Prince, H M

File(s) under permanent embargo

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

journal contribution

posted on 2019-01-01, 00:00 authored by N Horvath, A Spencer, M Kenealy, D Joshua, P J Campbell, J J Lee, J Hou, L Qiu, A Kalff, T Khong, A Londhe, S Siggins, M van Kooten Losio, M Eisbacher, H M Prince

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

History

Journal

Leukemia & Lymphoma

Volume

60

Issue

9

Pagination

2122 - 2133

Publisher

Taylor & Francis

Location

Abingdon, Eng.

Publisher DOI

https://doi.org/10.1080/10428194.2019.1579322

ISSN

1042-8194

eISSN

1029-2403

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

Keywords

Bortezomib consolidation multiple myeloma phase 3

File(s) under permanent embargo

Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study

History

Journal

Volume

Issue

Pagination

Publisher

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports